India Approves Pluvicto, Its First Radioligand Therapy for Advanced Prostate Cancer
India has approved Pluvicto, the first radioligand therapy (RLT) in the country for treating advanced prostate cancer. Radioligand therapy is a form of targeted nuclear medicine in which a radioactive substance is attach...